Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, today announced that it has been ranked at 317 on the Deloitte Technology Fast 500 EMEA 2011, a ranking of the 500 fastest growing technology companies in EMEA.  Rankings are based on percentage revenue growth over five year.  Lab21 Limited grew 527% during this period.

Lab21 Limited’s CEO, Graham Mullis, credits a combination of strong organic growth in its products and services divisions with good quality acquisitions and integrations to deliver the company’s 527% revenue growth over the past five years.  He said “I am proud Lab21 has been recognised by Deloitte in 2011 as one of the fastest growing technology companies in EMEA which is a great achievement and demonstrates how hard the Company and its employees have worked”.

“Making the Deloitte Technology Fast 500 is commendable in today’s highly competitive technology industry,” said David Halstead, Deloitte United Kingdom and partner in charge of the Deloitte Technology Fast 500 EMEA programme.  “We congratulate Lab21 Limited on being one of the 500 fastest growing technology companies in the region”.

Deloitte Technology Fast 500 EMEA selection and qualifications

The Technology Fast 500 list is compiled from the Deloitte EMEA Technology Fast 50 programmes, nominations submitted directly to the Technology Fast 500, and public company database research.  To qualify for the Technology Fast 500, entrants must have had base-year operating revenues of at least €50,000 and current-year operating revenues of at least €800,000.

Entrants must also be public or private companies headquartered in EMEA and must be a “technology company”, defined as a company that develops or owns proprietary technology that contributes to a significant portion of the company’s operating revenues; or manufactures a technology-related product; or devotes a high percentage of effort to the research and development of technology.  Using other companies’ technology in a unique way does not qualify.

ENDS

For further information:

Lab21
Graham Mullis, CEO

t: +44 1223 395450

e: graham.mullis@lab21.com

About Lab21
Lab21 is a global leader in personalised healthcare. It provides diagnostic products and services and supports blood bank screening, medical diagnostics and drug discovery. Lab21 customers include international healthcare providers, pharmaceutical and diagnostic companies. The Products division of Lab21 manufactures immunodiagnostic kits and reagents that are distributed internationally and is focused on infectious diseases for the blood-banking and clinical markets.  Our clinical services operations has a growing test portfolio providing companion diagnostics and high technology molecular assays. Lab21's corporate offices are based in Cambridge, UK and South Carolina, with a GMP manufacturing site in Cambridge and other manufacturing facilities in Newmarket, Camberley and Bridport. Website:  www.lab21.com    

About Deloitte Technology Fast 500 EMEA

The Deloitte Technology Fast 500 EMEA is the region’s most objective industry-ranking standard to focus on the technology field and recognises technology companies that have achieved the fastest rates of revenue growth in Europe, the Middle East and Africa during the past five years.  Combining technological innovation, entrepreneurship and rapid growth, Fast 500 companies – large, small, public and private – span a variety of industry sectors, and are leaders in hardware, software, telecom, semiconductors, internet, media, life sciences and emerging areas, such as clean technology.

The programme is supported by the Deloitte Technology Fast 50 initiatives, which rank high growth technology companies by location or specifically defined geographic area and is run by the Deloitte Touche Tohmatsu Limited’s Technology, Media & Telecommunications (TMT) global industry group.  Co-sponsors include Taylor Wessing, a leading International law firm with a focus on the industries of tomorrow, and Fidelity Growth Partners Europe, a venture and growth capital investor which backs entrepreneur with aspiration for greatness in the IT and clean technology sectors across Europe.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.  Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries.  With a globally connected network of member firms in more than 140 countries, Deloitte brings world-class capabilities and deep local expertise to help clients succeed wherever they operate.  Deloitte’s approximately 170,000 professionals are committed to becoming the standard of excellence.